Litcius/Paper detail

Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis

Robin Park, L. Lopes, Anwaar Saeed

2020Clinical & Translational Oncology47 citationsDOI

Topics & Concepts

MedicineMeta-analysisInternal medicineOncologyHazard ratioLung cancerCancerPublication biasAdverse effectReceiver operating characteristicOdds ratioRenal cell carcinomaConfidence intervalCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasFerroptosis and cancer prognosis
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis | Litcius